VEMURAFENIB IN TREATMENT OF MELANOMA WITH BRAIN METASTASES

VEMURAFENIB IN TREATMENT OF MELANOMA WITH BRAIN METASTASES

The effectiveness of traditional chemotherapy (with temozolomide, fotemustine, lomustine) alone or in combination with whole brain radiotherapy in melanoma patients with cerebral metastases does not exceed 7–10  % with no significant impact on survival, which is around 2–4  months. Targeted therapy...

Full description

Saved in:
Bibliographic Details
Main Authors: D. R. Naskhletashvili, V. A. Gorbunova, A. Kh. Bekyashev, L. V. Demidov, G. Yu. Kharkevich, S. M. Banov, I. V. Samoylenko, K. А. Baryshnikov, K. V. Orlova, I. А. Utyashev, N. N. Petenko, I. G. Markina, E. A. Moskvina, S. V. Medvedev
Format: Article
Language:Russian
Published: ABV-press 2017-04-01
Series:Опухоли головы и шеи
Subjects:
vemurafenib
melanoma
brain metastases
targeted therapy
Online Access:https://ogsh.abvpress.ru/jour/article/view/248
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://ogsh.abvpress.ru/jour/article/view/248

Similar Items